Ozempic's popularity leads to shortages for people with Type 2 diabetes
Drugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can't get them when they need them.
weight loss
Popular for weight loss, intermittent fasting may help with diabetes too
New research finds that limiting eating from noon to 8 p.m. helped patients manage weight and blood sugar as much as calorie counting – and was easier to keep up.
Ozempic seems to curb cravings for alcohol. Here's what scientists think is going on
People taking weight-loss drugs Ozempic and Wegovy report a dampening of the urge to drink. Here's how the drugs curb cravings and what that could mean for helping treat addiction.
There's a way to get healthier without even going to a gym. It's called NEAT
All those daily activities we'd rather avoid — taking the stairs, cleaning the house etc. — have a big metabolic payoff. Non-exercise activity thermogenesis can help manage weight and boost health.
Intermittent fasting is as effective as counting calories, new study finds
Limiting when you eat to a six- or eight-hour window can help reduce caloric intake. While the weight loss isn't dramatic, it may be easier to stick to than counting calories.
'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug
The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.
New childhood obesity guidance raises worries over the risk of eating disorders
Many eating disorder specialists oppose the new guidance's focus on weight loss and BMI, and say it minimizes the risk of disordered eating and will perpetuate deep-rooted, damaging stigmas.
Why Crash Weight Loss Programs Don't Work: Clues From Hunter-Gatherer Societies
Evolutionary anthropologist Herman Pontzer shares why some of the most physically active people in the world don't burn more calories than office workers. And what that means for your fitness goals.
Obesity Drug's Promise Now Hinges On Insurance Coverage
Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.
When Your Fad Diet Fails, And It Probably Will, 'Just Eat'
Diets often fail in the long term because they're too strict or require unnatural eating habits. In a new book, Barry Estabrook turns to science and history to find a weight-loss regimen that works.